U.S. Capital Wealth Advisors’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,500
Closed -$308K 676
2022
Q1
$308K Hold
10,500
0.01% 598
2021
Q4
$409K Hold
10,500
0.02% 549
2021
Q3
$405K Buy
+10,500
New +$426K 0.02% 545

Other funds holding BSTZ

U.S. Capital Wealth Advisors's BSTZ Position: Q2 2022 in Review

U.S. Capital Wealth Advisors sold out of BlackRock Science and Technology Term Trust (BSTZ) in Q2 2022, closing a stake of 10,500 shares — an estimated $308K sold.

U.S. Capital Wealth Advisors first reported a position in BSTZ in Q3 2021 and held it in 3 quarters. The position peaked at $409K in Q4 2021. 92 funds tracked by Wall St. Rank hold BSTZ as of Q2 2022.

  • U.S. Capital Wealth Advisors reported no remaining BlackRock Science and Technology Term Trust position as of Q2 2022 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 10,500 BlackRock Science and Technology Term Trust shares in Q2 2022, an estimated $308K.
  • U.S. Capital Wealth Advisors first reported a position in BlackRock Science and Technology Term Trust in Q3 2021 and held it in 3 quarters.
  • U.S. Capital Wealth Advisors's BlackRock Science and Technology Term Trust position peaked at $409K in Q4 2021.
  • 92 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q2 2022.

Based on U.S. Capital Wealth Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.